PEREGRINE CAPITAL MANAGEMENT LLC
Position in KNSA — Kiniksa Pharmaceuticals International, plc
CIK 764529
MINNEAPOLIS, MN
Position in KNSA
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$10,325,622
+$1,593,138 QoQ
Shares Held
161,464
-11.0% QoQ
Ownership
0.103%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#52
of 266 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 36%
Shared 0%
None 64%
Common Shares in KNSA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PEREGRINE CAPITAL MANAGEMENT LLC holds $27,179,481 across 3 Drug Manufacturers - Specialty & Generic names. KNSA ranks #2 (38.0% of the industry book) .
All Filings in KNSA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,325,622 | 161,464 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $8,732,484 | 181,360 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $8,700,037 | 210,910 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $8,323,754 | 214,364 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $7,986,558 | 288,636 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $6,867,109 | 309,190 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $4,827,170 | 244,043 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $5,989,653 | 239,682 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $4,465,042 | 239,156 | Shares | Sole | 2024-07-29 | |
| No filing history on record for this holder in this stock. | ||||||